Jeil Pharmaceutical to Seek Licensing Deals for Diabetes and Cancer Drug Candidates at BIO-Europe
AI 요약 정보
- Jeil seeks deals for JP-2266 and cancer drug JP9441
- Jeil prepares JP-2266 for Phase 3 after Phase 2
- Duglow overseas licensing partners sought at BIO-Europe